Congress Flounders on Bipartisan Attempt to Lower Insulin Costs

Senate Democrats put a central piece of their drug pricing agenda into the hands of their Republican colleagues, only to learn they’re not rushing to hand over a win.

That trust may delay a price cap on insulin, which can cost nearly $100 per vial in the US, more than five times the average cost in Canada.

Senate Majority Leader Chuck Schumer has said he plans to hold a vote soon on a measure from a bipartisan duo to cap the out-of-pocket cost of insulin at $35 a month. But passing the legislation from Sens. Susan Collins (R-Maine) and Jeanne ...